Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
about
Mononuclear cell recruitment, granuloma assembly, and response to treatment in experimental visceral leishmaniasis: intracellular adhesion molecule 1-dependent and -independent regulationTreatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trialMycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12Antileishmanial activity of the terpene nerolidol.Immune regulation during chronic visceral leishmaniasis.Clinical and experimental advances in treatment of visceral leishmaniasis.Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Tissue granuloma structure-function in experimental visceral leishmaniasis.Treatment of visceral leishmaniasis: a review of current treatment practices.The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesisTreatment of leishmaniasis in HIV-positive patients.Bioactivity Evaluation of Plant Extracts Used in Indigenous Medicine against the Snail, Biomphalaria glabrata, and the Larvae of Aedes aegypti.Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.Effects of combined therapy with thalidomide and glucantime on leishmaniasis induced by Leishmania major in BALB/c miceMicroscopy and polymerase chain reaction detection of Leishmania chagasi in the pleural and ascitic fluid of a patient with AIDS: Case report and review of diagnosis and therapy of visceral leishmaniasis.A controlled, randomized nonblinded clinical trial to assess the efficacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India.Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization.Suppression of posttreatment recurrence of experimental visceral Leishmaniasis in T-cell-deficient mice by oral miltefosine.16alpha-Hydroxycleroda-3,13 (14)Z-dien-15,16-olide from Polyalthia longifolia: a safe and orally active antileishmanial agent.In vitro activities of 7-substituted 9-chloro and 9-amino-2-methoxyacridines and their bis- and tetra-acridine complexes against Leishmania infantumVisceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar.Factors of poor prognosis of visceral leishmaniasis among children under 12 years of age. A retrospective monocentric study in Belo Horizonte, State of Minas Gerais, Brazil, 2001-2005.Cloning of S-adenosyl-L-methionine:C-24-Delta-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-Resistant promastigotesHepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice.Phospholipases a in trypanosomatids.The metabolism of S-nitrosothiols in the trypanosomatids: the role of ovothiol A and trypanothione.Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India.Methods to Evaluate the Preclinical Safety and Immunogenicity of Genetically Modified Live-Attenuated Leishmania Parasite Vaccines.Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.[What is a granuloma?]
P2860
Q28344860-25AD8366-2E38-4B92-A4C5-9CE85AA4D4DDQ28346660-663DF45B-1B34-48A3-BAB1-368479B988ECQ28480989-E8CDD72C-754D-49BA-B720-58EB483ACE36Q33770134-F31560D7-51F6-4D13-B2C4-DEA38E0B7368Q33881718-E65FEC94-2D05-4CEE-BBF4-79B00586D4AFQ33982648-7677BA82-BC91-4A77-B8AE-E1B16EB28890Q34181985-544ED46E-C683-47DB-B979-DBF412251F0BQ34434760-22AB9317-CF86-40BA-B0A0-0EDB44DFA14BQ34768497-C9151329-C49F-48F2-ACCA-99CA76883EBCQ34940857-FC81A08B-CE0A-4EBD-96E0-68353ED48811Q35609052-077366AE-6D28-4C6F-AE67-2FB9572FFDC6Q35615409-3C10A92F-F645-4372-A248-D0361928C0A2Q35917392-45444E0B-E2E5-4CA1-8C6B-41EBEB830B4CQ36118527-86BF3FCC-7A3A-4009-82B5-3A4E50FD7F80Q36868265-043860C6-E6BE-47CF-8F20-177136E7D97EQ37045139-1479278E-78B3-47B5-AADD-FAFC7DDAEF07Q37230269-3A302B23-CE18-4018-BE5A-C37037C70A60Q38929692-05DF68FE-0498-417A-93E3-5D53B8D8524FQ39537428-B095BF67-1FDD-41B5-9F86-F09F302993CCQ39640638-5BC4AEB2-CAB8-451E-A488-8E8BC945508BQ39730709-B4494F96-59BA-4E2E-919C-B393B8F02D86Q39805622-D6409D5F-F6BB-4094-91A7-F18FF8E562B6Q40251989-586FA262-C0EF-4953-A847-997A6F149C05Q40968271-242A3E5C-6303-48A9-BE41-D5DB98641A84Q41043666-C4078277-A7CC-4138-A349-50906C3084A2Q42716413-084620ED-850A-44C6-A8A8-CAFC3685A0FFQ43002763-119E9A16-A6B5-4CBC-A408-1857BEAE10C8Q44731161-7377E122-DA3B-4215-8C6D-46B0E14166E6Q50791211-72EC9EE7-7067-46EC-B9D7-A22A171B72EDQ51372327-66EFFD42-3023-45E9-B3B9-B2A734ABBFA4Q53544999-1A938A09-D59D-49DA-8357-D2874DCD0B36Q54251576-F7694E22-9412-4E87-B9AF-B419E91B88E5
P2860
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Treatment of visceral leishman ...... rogress and future approaches.
@ast
Treatment of visceral leishman ...... rogress and future approaches.
@en
Treatment of visceral leishmaniasis
@nl
type
label
Treatment of visceral leishman ...... rogress and future approaches.
@ast
Treatment of visceral leishman ...... rogress and future approaches.
@en
Treatment of visceral leishmaniasis
@nl
prefLabel
Treatment of visceral leishman ...... rogress and future approaches.
@ast
Treatment of visceral leishman ...... rogress and future approaches.
@en
Treatment of visceral leishmaniasis
@nl
P1476
Treatment of visceral leishman ...... rogress and future approaches.
@en
P2093
P304
P356
10.1016/S1201-9712(00)90078-X
P577
2000-01-01T00:00:00Z